{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:59:31Z","timestamp":1792519171608,"version":"4.5.0"},"reference-count":91,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Reports"],"abstract":"<jats:p>Background\/Objectives: Antimicrobial resistance (AMR) is a major global public health threat, compromising prevention and treatment of infectious diseases. This narrative review examines AMR as a multifactorial and transnational crisis through epidemiological, One Health, social and bioethical perspectives, and discusses emerging non-antibiotic preventive and therapeutic strategies. Methods: PubMed and Scopus were searched using terms related to AMR, epidemiology, public health, surveillance, One Health, bioethics, equity and alternative therapies. Peer-reviewed medical and public health articles were considered, together with selected reports from international organizations and public health agencies. Results: AMR is driven by inappropriate antibiotic use in human medicine, livestock, aquaculture and agriculture, combined with weaknesses in infection prevention, stewardship, environmental control and surveillance. Epidemiological evidence shows a substantial global burden, marked regional inequalities in resistance patterns, surveillance capacity and policy response, and major consequences, including increased mortality, prolonged hospitalization, rising healthcare costs and disproportionate effects on vulnerable populations. Key bioethical concerns include collective responsibility, equitable access to effective treatment, stewardship, global justice and intergenerational accountability. Emerging non-antibiotic strategies vary in translational maturity: vaccines and selected microbiome-based interventions have preventive or supportive roles in defined settings, bacteriophage therapy is used mainly in compassionate or specialized contexts, and many antimicrobial peptides and nanotechnology-based platforms remain experimental or early translational. Conclusions: AMR requires coordinated global action grounded in One Health, strong public health systems, integrated surveillance, responsible antimicrobial use and sustained innovation. Effective containment must also address social inequalities, ethical stewardship, equitable access to diagnostics and treatment, and responsibility toward future generations.<\/jats:p>","DOI":"10.3390\/idr18040070","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:16:44Z","timestamp":1783613804000},"page":"70","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antimicrobial Resistance as a Global Public Health Challenge: Epidemiological Burden, Bioethical Dimensions and Emerging Therapeutic Strategies"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2749-101X","authenticated-orcid":false,"given":"Christos","family":"Ntais","sequence":"first","affiliation":[{"name":"Epidemiology Program, School of Science and Technology, Hellenic Open University, 26335 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6242-1351","authenticated-orcid":false,"given":"Ioanna P.","family":"Chatziprodromidou","sequence":"additional","affiliation":[{"name":"Department of Public Health, Medical School, University of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Salam, M.A., Al-Amin, M.Y., Salam, M.T., Pawar, J.S., Akhter, N., Rabaan, A.A., and Alqumber, M.A.A. (2023). Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare, 11.","DOI":"10.20944\/preprints202305.0555.v1"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"EClinicalMedicine (2021). Antimicrobial Resistance: A Top Ten Global Public Health Threat. EClinicalMedicine, 41, 101221.","DOI":"10.1016\/j.eclinm.2021.101221"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Walsh, T.R., Gales, A.C., Laxminarayan, R., and Dodd, P.C. (2023). Antimicrobial Resistance: Addressing a Global Threat to Humanity. PLoS Med., 20.","DOI":"10.1371\/journal.pmed.1004264"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s44259-024-00052-5","article-title":"Antibiotic Resistance Mediated by Gene Amplifications","volume":"2","author":"Silva","year":"2024","journal-title":"npj Antimicrob. Resist."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Galgano, M., Pellegrini, F., Catalano, E., Capozzi, L., Del Sambro, L., Sposato, A., Lucente, M.S., Vasinioti, V.I., Catella, C., and Odigie, A.E. (2025). Acquired Bacterial Resistance to Antibiotics and Resistance Genes: From Past to Future. Antibiotics, 14.","DOI":"10.3390\/antibiotics14030222"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"de Kraker, M.E.A., Stewardson, A.J., and Harbarth, S. (2016). Will 10 Million People Die a Year Due to Antimicrobial Resistance by 2050?. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002184"},{"key":"ref_8","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators (2024). Global Burden of Bacterial Antimicrobial Resistance 1990\u20132021: A Systematic Analysis with Forecasts to 2050. Lancet, 404, 1199\u20131226."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"dlad062","DOI":"10.1093\/jacamr\/dlad062","article-title":"Drivers of Inappropriate Antibiotic Use in Low- and Middle-Income Countries","volume":"5","author":"Otaigbe","year":"2023","journal-title":"JAC. Antimicrob. Resist."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4236\/pp.2024.1512028","article-title":"The Misuse of Antibiotics and the Rise of Bacterial Resistance: A Global Concern","volume":"15","author":"Kilari","year":"2024","journal-title":"Pharmacol. Pharm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ajic.2024.02.008","article-title":"Prevalence of Self-Medication with Antibiotics and Its Related Factors among the General Public and Health Professionals during the COVID-19 Pandemic: A Cross-Sectional Study in China","volume":"52","author":"Li","year":"2024","journal-title":"Am. J. Infect. Control"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rahman, S., and Hollis, A. (2023). The Effect of Antibiotic Usage on Resistance in Humans and Food-Producing Animals: A Longitudinal, One Health Analysis Using European Data. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1170426"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"100647","DOI":"10.1016\/j.onehlt.2023.100647","article-title":"Evaluating the Contribution of Antimicrobial Use in Farmed Animals to Global Antimicrobial Resistance in Humans","volume":"17","author":"Ardakani","year":"2023","journal-title":"One Health"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5187\/jast.2023.e129","article-title":"Antibiotic Resistance in Livestock, Environment and Humans: One Health Perspective","volume":"66","author":"Pandey","year":"2024","journal-title":"J. Anim. Sci. Technol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Mo, Y., Oonsivilai, M., Lim, C., Niehus, R., and Cooper, B.S. (2023). Implications of Reducing Antibiotic Treatment Duration for Antimicrobial Resistance in Hospital Settings: A Modelling Study and Meta-Analysis. PLoS Med., 20.","DOI":"10.1371\/journal.pmed.1004013"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41564-024-01891-8","article-title":"ESKAPE Pathogens Rapidly Develop Resistance against Antibiotics in Development in Vitro","volume":"10","author":"Daruka","year":"2025","journal-title":"Nat. Microbiol."},{"key":"ref_17","first-page":"2200082","article-title":"A Step Forward in Antibiotic Use and Resistance Monitoring: A Quarterly Surveillance System Pilot in 11 European Union\/European Economic Area Countries, September 2017 to May 2020","volume":"27","author":"Molvik","year":"2022","journal-title":"Euro Surveill."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/QCO.0000000000000080","article-title":"Back to Basics: Hand Hygiene and Isolation","volume":"27","author":"Huang","year":"2014","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41429-020-0300-y","article-title":"Industry Incentives and Antibiotic Resistance: An Introduction to the Antibiotic Susceptibility Bonus","volume":"73","author":"Morel","year":"2020","journal-title":"J. Antibiot."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100962","DOI":"10.1016\/j.lanmic.2024.100962","article-title":"Antibacterial Agents in Preclinical and Clinical Development","volume":"5","author":"Jesudason","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/sur.2020.145","article-title":"Increasing Globalization and the Movement of Antimicrobial Resistance between Countries","volume":"21","author":"Berndtson","year":"2020","journal-title":"Surg. Infect."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/QCO.0000000000000751","article-title":"Antimicrobial-Resistant Bacteria in International Travelers","volume":"34","author":"Sridhar","year":"2021","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kanan, M., Ramadan, M., Haif, H., Abdullah, B., Mubarak, J., Ahmad, W., Mari, S., Hassan, S., Eid, R., and Hasan, M. (2023). Empowering Low- and Middle-Income Countries to Combat AMR by Minimal Use of Antibiotics: A Way Forward. Antibiotics, 12.","DOI":"10.3390\/antibiotics12101504"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/S0140-6736(24)00862-6","article-title":"Burden of Bacterial Antimicrobial Resistance in Low-Income and Middle-Income Countries Avertible by Existing Interventions: An Evidence Review and Modelling Analysis","volume":"403","author":"Lewnard","year":"2024","journal-title":"Lancet"},{"key":"ref_25","unstructured":"FAO, UNEP, WHO, and WOAH (2022). One Health Joint Plan of Action (2022\u20132026): Working Together for the Health of Humans, Animals, Plants and the Environment, WOAH. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240059139."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"United Nations Environment Programme (2023). Bracing for Superbugs: Strengthening Environmental Action in the One Health Response to Antimicrobial Resistance, WHO. Available online: https:\/\/www.unep.org\/resources\/superbugs\/environmental-action.","DOI":"10.18356\/9789210025799"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41579-021-00649-x","article-title":"Antibiotic Resistance in the Environment","volume":"20","author":"Larsson","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e00088-17","DOI":"10.1128\/CMR.00088-17","article-title":"Mobile Genetic Elements Associated with Antimicrobial Resistance","volume":"31","author":"Partridge","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Tang, K.W.K., Millar, B.C., and Moore, J.E. (2023). Antimicrobial Resistance (AMR). Br. J. Biomed. Sci., 80.","DOI":"10.3389\/bjbs.2023.11387"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"World Health Organization (2025). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2025, WHO. Available online: https:\/\/www.who.int\/initiatives\/glass.","DOI":"10.2471\/B09585"},{"key":"ref_31","unstructured":"Centers for Disease Control and Prevention (2019). Antibiotic Resistance Threats in the United States, Department of Health and Human Services."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"ofad684","DOI":"10.1093\/ofid\/ofad684","article-title":"An Update from the National Healthcare Safety Network on Hospital Antibiotic Stewardship Programs in the United States, 2014\u20132021","volume":"11","author":"Neuhauser","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"ref_33","unstructured":"European Centre for Disease Prevention and Control (2025). Antimicrobial Resistance in the EU\/EEA (EARS-Net)-Annual Epidemiological Report 2024, ECDC. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/antimicrobial-resistance-eu-annual-epidemiological-report-2024.pdf."},{"key":"ref_34","unstructured":"European Centre for Disease Prevention and Control (2024). ECDC Country Visit to Greece to Discuss Antimicrobial Resistance Issues, 15\u201319 April 2024, ECDC."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13756-024-01367-8","article-title":"Healthcare-Associated Infections and Antimicrobial Use in Acute Care Hospitals in Greece, 2022; Results of the Third Point Prevalence Survey","volume":"13","author":"Palaiopanos","year":"2024","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_36","first-page":"e42231","article-title":"The Challenge of Antimicrobial Resistance in the Indian Healthcare System","volume":"15","author":"Sharma","year":"2023","journal-title":"Cureus"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"100412","DOI":"10.1016\/j.lansea.2024.100412","article-title":"Emerging Trends in Antimicrobial Resistance in Bloodstream Infections: Multicentric Longitudinal Study in India (2017\u20132022)","volume":"26","author":"Kaur","year":"2024","journal-title":"Lancet Reg. Health Southeast Asia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jgar.2024.02.022","article-title":"Changes in Antimicrobial Resistance of Escherichia Coli Isolated from Community-Associated Urinary Tract Infection before and during the COVID-19 Pandemic in India","volume":"37","author":"Venugopal","year":"2024","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1016\/S2214-109X(23)00539-9","article-title":"The Burden of Bacterial Antimicrobial Resistance in the WHO African Region in 2019: A Cross-Country Systematic Analysis","volume":"12","author":"Sartorius","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"ref_40","first-page":"100561","article-title":"The Burden of Antimicrobial Resistance in the Americas in 2019: A Cross-Country Systematic Analysis","volume":"25","author":"Aguilar","year":"2023","journal-title":"Lancet Reg. Health Am."},{"key":"ref_41","first-page":"100596","article-title":"Lives Lost and Disease Burden Related to Antimicrobial Resistance in the Americas Can No Longer Be Ignored","volume":"26","author":"Undurraga","year":"2023","journal-title":"Lancet Reg. Health Am."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Bertagnolio, S., Suthar, A.B., Tosas, O., and Van Weezenbeek, K. (2023). Antimicrobial Resistance: Strengthening Surveillance for Public Health Action. PLoS Med., 20.","DOI":"10.1371\/journal.pmed.1004265"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3201\/EID2003.121157","article-title":"Surveillance for Antimicrobial Drug Resistance in Under-Resourced Countries","volume":"20","author":"Vernet","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"13855","DOI":"10.1136\/bmjgh-2023-013855","article-title":"Global Approaches to Tackling Antimicrobial Resistance: A Comprehensive Analysis of Water, Sanitation and Hygiene Policies","volume":"9","author":"Weets","year":"2024","journal-title":"BMJ Glob. Health"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Do, P.C., Assefa, Y.A., Batikawai, S.M., and Reid, S.A. (2023). Strengthening Antimicrobial Resistance Surveillance Systems: A Scoping Review. BMC Infect. Dis., 23.","DOI":"10.1186\/s12879-023-08585-2"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Kim, H., Park, J.S., Kim, D., Kim, H.J., Shin, J.H., Kim, Y.A., Uh, Y., Kim, S.H., Shin, J.H., and Jeong, S.H. (2024). Standardization of an Antimicrobial Resistance Surveillance Network through Data Management. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1411145"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s44259-025-00105-3","article-title":"Tools and Challenges in the Use of Routine Clinical Data for Antimicrobial Resistance Surveillance","volume":"3","author":"Holt","year":"2025","journal-title":"npj Antimicrob. Resist."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12992-024-01046-8","article-title":"AMR and Sustainable Development Goals: At a Crossroads","volume":"20","author":"Aslam","year":"2024","journal-title":"Glob. Health"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1208\/s12248-025-01080-3","article-title":"Social Inequality and Antimicrobial Resistance: An Interconnected Global Problem","volume":"27","author":"Vitiello","year":"2025","journal-title":"AAPS J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/2042098614554919","article-title":"Antimicrobial Resistance: Risk Associated with Antibiotic Overuse and Initiatives to Reduce the Problem","volume":"5","author":"Llor","year":"2014","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Nguyen, H.Q., Nguyen, N.T.Q., Hughes, C.M., and O\u2019Neill, C. (2019). Trends and Impact of Antimicrobial Resistance on Older Inpatients with Urinary Tract Infections (UTIs): A National Retrospective Observational Study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223409"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"100947","DOI":"10.1016\/j.lanmic.2024.07.010","article-title":"Antimicrobial Resistance: A Concise Update","volume":"6","author":"Ho","year":"2025","journal-title":"Lancet Microbe"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S1473-3099(15)00270-4","article-title":"Potential Burden of Antibiotic Resistance on Surgery and Cancer Chemotherapy Antibiotic Prophylaxis in the USA: A Literature Review and Modelling Study","volume":"15","author":"Teillant","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Rallis, D., Giapros, V., Serbis, A., Kosmeri, C., and Baltogianni, M. (2023). Fighting Antimicrobial Resistance in Neonatal Intensive Care Units: Rational Use of Antibiotics in Neonatal Sepsis. Antibiotics, 12.","DOI":"10.3390\/antibiotics12030508"},{"key":"ref_55","unstructured":"McDonnell, A., Countryman, A., Laurence, T., Gulliver, S., Drake, T., Edwards, S., Kenny, C., Lamberti, O., Morton, A., and Shafira, A. (2024). Forecasting the Fallout from AMR: Economic Impacts of Antimicrobial Resistance in Humans\u2014A Report from the EcoAMR Series, World Organisation for Animal Health and World Bank."},{"key":"ref_56","unstructured":"(2026, March 16). By 2050, Drug-Resistant Infections Could Cause Global Economic Damage on Par with 2008 Financial Crisis. World Bank Group. Available online: https:\/\/www.worldbank.org\/en\/news\/press-release\/2016\/09\/18\/by-2050-drug-resistant-infections-could-cause-global-economic-damage-on-par-with-2008-financial-crisis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1016\/S2214-109X(23)00554-5","article-title":"Antimicrobial Resistance and the Great Divide: Inequity in Priorities and Agendas between the Global North and the Global South Threatens Global Mitigation of Antimicrobial Resistance","volume":"12","author":"Mendelson","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Parsonage, B., Hagglund, P.K., Keogh, L., Wheelhouse, N., Brown, R.E., and Dancer, S.J. (2017). Control of Antimicrobial Resistance Requires an Ethical Approach. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.02124"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12992-023-00930-z","article-title":"Balancing the Risks and Benefits of Antibiotic Use in a Globalized World: The Ethics of Antimicrobial Resistance","volume":"19","author":"Adebisi","year":"2023","journal-title":"Glob. Health"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijantimicag.2015.06.010","article-title":"Antibiotic Resistance: An Ethical Challenge","volume":"46","author":"Littmann","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_61","unstructured":"Beauchamp, T.L., and Childress, J.F. (2019). Principles of Biomedical Ethics, Oxford University Press. [8th ed.]."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jiph.2021.12.008","article-title":"Menace of Antimicrobial Resistance in LMICs: Current Surveillance Practices and Control Measures to Tackle Hostility","volume":"15","author":"Sharma","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"12874","DOI":"10.1136\/bmjgh-2023-012874","article-title":"Interventions to Address Antimicrobial Resistance: An Ethical Analysis of Key Tensions and How They Apply in Low- Income and Middle-Income Countries","volume":"9","author":"Pokharel","year":"2024","journal-title":"BMJ Glob. Health"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bioe.12958","article-title":"Individual Moral Responsibility for Antibiotic Resistance","volume":"36","author":"Ancillotti","year":"2022","journal-title":"Bioethics"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/bacteria3030012","article-title":"Antimicrobial Resistance and Novel Alternative Approaches to Conventional Antibiotics","volume":"3","author":"Berger","year":"2024","journal-title":"Bacteria"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"127275","DOI":"10.1016\/j.micres.2022.127275","article-title":"Antibiotic Resistance and the Alternatives to Conventional Antibiotics: The Role of Probiotics and Microbiota in Combating Antimicrobial Resistance","volume":"267","author":"Aghamohammad","year":"2023","journal-title":"Microbiol. Res."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Kumar, M., Sarma, D.K., Shubham, S., Kumawat, M., Verma, V., Nina, P.B., JP, D., Kumar, S., Singh, B., and Tiwari, R.R. (2021). Futuristic Non-Antibiotic Therapies to Combat Antibiotic Resistance: A Review. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.609459"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Alaoui Mdarhri, H., Benmessaoud, R., Yacoubi, H., Seffar, L., Guennouni Assimi, H., Hamam, M., Boussettine, R., Filali-Ansari, N., Lahlou, F.A., and Diawara, I. (2022). Alternatives Therapeutic Approaches to Conventional Antibiotics: Advantages, Limitations and Potential Application in Medicine. Antibiotics, 11.","DOI":"10.3390\/antibiotics11121826"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Hetta, H.F., Ramadan, Y.N., Al-Harbi, A.I., Ahmed, E.A., Battah, B., Abd Ellah, N.H., Zanetti, S., and Donadu, M.G. (2023). Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020413"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"143895","DOI":"10.1016\/j.jclepro.2024.143895","article-title":"Emerging Global Trends in Next-Generation Alternatives to Classic Antibiotics for Combatting Multidrug-Resistant Bacteria","volume":"478","year":"2024","journal-title":"J. Clean. Prod."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e187996","DOI":"10.1172\/JCI187996","article-title":"Bacteriophage Therapy for Multidrug-Resistant Infections: Current Technologies and Therapeutic Approaches","volume":"135","author":"Kim","year":"2025","journal-title":"J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40560-024-00759-7","article-title":"Current Status of Bacteriophage Therapy for Severe Bacterial Infections","volume":"12","author":"Sawa","year":"2024","journal-title":"J. Intensive Care"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.molmed.2025.03.013","article-title":"The Future of Phage Therapy in the USA","volume":"31","author":"Berryhill","year":"2025","journal-title":"Trends Mol. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e0211524","DOI":"10.1128\/aem.02115-24","article-title":"Antimicrobial Peptides: From Discovery to Developmental Applications","volume":"91","author":"Zhang","year":"2025","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Chen, C.H., and Lu, T.K. (2020). Development and Challenges of Antimicrobial Peptides for Therapeutic Applications. Antibiotics, 9.","DOI":"10.3390\/antibiotics9010024"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12967-025-06321-9","article-title":"Antimicrobial Peptide Biological Activity, Delivery Systems and Clinical Translation Status and Challenges","volume":"23","author":"Zheng","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Khan Laghari, I., Nawaz, T., Mustafa, S., Jamali, A.A., and Fatima, S. (2023). Role of Multi-Strain Probiotics in Preventing Severity and Frequency of Recurrent Respiratory Tract Infections in Children. BMC Pediatr., 23.","DOI":"10.1186\/s12887-023-04338-x"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MOG.0000000000000410","article-title":"Probiotics for Prevention of Clostridium Difficile Infection","volume":"34","author":"Mills","year":"2018","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41390-020-01298-1","article-title":"Perspectives from the Society for Pediatric Research: Probiotic Use in Urinary Tract Infections, Atopic Dermatitis, and Antibiotic-Associated Diarrhea: An Overview","volume":"90","author":"Forster","year":"2021","journal-title":"Pediatr. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.1224203","article-title":"The Application of Ecological Theory towards an Understanding of the Human Microbiome","volume":"336","author":"Costello","year":"2012","journal-title":"Science"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1021\/acsinfecdis.5c00001","article-title":"Recent Advances in Immunotherapeutic and Vaccine-Based Approaches for the Treatment of Drug-Resistant Bacterial Infections","volume":"11","author":"Odoom","year":"2025","journal-title":"ACS Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41579-020-00506-3","article-title":"The Role of Vaccines in Combatting Antimicrobial Resistance","volume":"19","author":"Micoli","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Chen, H.C., Pan, Y.L., Chen, Y., Yang, T.H., Hsu, E.T., Huang, Y.T., and Chiang, M.H. (2024). Monoclonal Antibodies as a Therapeutic Strategy against Multidrug-Resistant Bacterial Infections in a Post-COVID-19 Era. Life, 14.","DOI":"10.3390\/life14020246"},{"key":"ref_84","unstructured":"World Health Organization (2022). Bacterial Vaccines in Clinical and Preclinical Development 2021: An Overview and Analysis, WHO. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240052451."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"100112","DOI":"10.1016\/j.tcsw.2023.100112","article-title":"Alternative Mechanisms of Action of Metallic Nanoparticles to Mitigate the Global Spread of Antibiotic-Resistant Bacteria","volume":"10","author":"Girma","year":"2023","journal-title":"Cell Surf."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"22374","DOI":"10.1038\/s41598-024-71959-2","article-title":"Study on the Mechanism of ROS-Induced Oxidative Stress Injury and the Broad-Spectrum Antimicrobial Performance of Nickel Ion-Doped V6O13 Powder","volume":"14","author":"Liu","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"106515","DOI":"10.1016\/j.ejps.2023.106515","article-title":"Nanoparticles-Based Therapeutics for the Management of Bacterial Infections: A Special Emphasis on FDA Approved Products and Clinical Trials","volume":"188","author":"Aflakian","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","article-title":"A Deep Learning Approach to Antibiotic Discovery","volume":"180","author":"Stokes","year":"2020","journal-title":"Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41589-023-01349-8","article-title":"Deep Learning-Guided Discovery of an Antibiotic Targeting Acinetobacter baumannii","volume":"19","author":"Liu","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-018-0098-9","article-title":"Developmental Roadmap for Antimicrobial Susceptibility Testing Systems","volume":"17","author":"Bachmann","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_91","unstructured":"World Health Organization (2022). Global Genomic Surveillance Strategy for Pathogens with Pandemic and Epidemic Potential, 2022\u20132032, WHO. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240046979."}],"container-title":["Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7449\/18\/4\/70\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:37:55Z","timestamp":1783615075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7449\/18\/4\/70"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":91,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["idr18040070"],"URL":"https:\/\/doi.org\/10.3390\/idr18040070","relation":{},"ISSN":["2036-7449"],"issn-type":[{"value":"2036-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]}}}